HTRF - S1/ace2 binding - 500 tests 1 Kit
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
ACE2 is a human cell surface receptor that has been identified as the main point of entry for SARS-CoV-2 virions, which match and bind ACE2 with their own viral Spike protein S1 subunits. This interaction is therefore a key target in COVID-19 therapeutic research, as its inhibitors may yield a protective effect by preventing SARS-CoV-2 entry into cells. For this reason, protein-protein interaction assays suitable for ACE2-Spike inhibitor screening are relevant to current research.
Garantie
Garantie 0 Mois
Description
ACE2 is a human cell surface receptor that has been identified as the main point of entry for SARS-CoV-2 virions, which match and bind ACE2 with their own viral Spike protein S1 subunits. This interaction is therefore a key target in COVID-19 therapeutic research, as its inhibitors may yield a protective effect by preventing SARS-CoV-2 entry into cells. For this reason, protein-protein interaction assays suitable for ACE2-Spike inhibitor screening are relevant to current research.
Caractéristiques
- Marque
- REVVITY
- Libellé produit fabricant
- SARS-CoV-2 S1/ACE2 binding kit, 500 Tests
- Référence distributeur
- 64BDS1PEG
- Référence fabricant
- 64BDS1PEG
- Fournisseur
- REVVITY
- Reprise en cas d’erreur client
- non
- Lieu de fabrication
- France
- Lieu de stockage
- France
- Domaine de recherche
- biochimie
- Délai de péremption à la date de livraison
- 6 mois
- Soumis à réglementation
- non
- Température de conservation (°C)
- -80 à -60 °C
- Type d’application
- dosage biochimique
- Vendu par
- 1 kit
- Quantité
- N/A
- Nomenclature Nacres
- NA.84
- Nomenclature CEA
- SGP01
- Nomenclature IRSN
- 273
- Nomenclature INSERM
- NA.NA84
- Nomenclature CNRS
- NA84
- Nomenclature CHU
- 18.551
- Nomenclature DGOS
- LD11AOOO
- Type d'échantillon
- protéine
- Certification
- RUO